Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2018
Price : $35 *
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 06 Feb 2018 Status changed from recruiting to completed.
- 23 May 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Oct 2017.